期刊文献+

不同预后尖锐湿疣组织中Toll样受体3、9的表达 被引量:5

Expressions of Toll like receptor 3 (TLR3) and TLR9 in lesions of condyloma acuminatum with different prognosis
原文传递
导出
摘要 目的探讨不同预后尖锐湿疣(CA)患者皮损局部T0u样受体3(TLR3)和Toll样受体9(TLR9)表达定位及TLR3mRNA、TLR9mRNA的表达情况。方法免疫组化SP法及反转录聚合酶链反应(RT—PCR)法检测10例CA复发者、14例CA无复发者及10例包皮组织中TLR3及TLR9表达情况。结果TLR3、TLR9在无复发CA皮损中表达以棘层、颗粒层为主;在复发组CA皮损中表达以基底层、棘层为主。无复发组CA组织中TLR3mRNA表达较对照组及复发组均明显升高(P〈0.01、P〈0.05),TLR9mRNA较对照组明显升高(P〈0.05),较复发组差异无统计学意义。结论表皮TLR3及TLR9的表达部位和表达量的改变可能与CA预后有关,TLR3的影响可能更大。 Objective To investigate the location of TLR3 and TLR9 protein as well as the expressions of TLR3 and TLR9 protein and mRNA in the lesions of condyloma acuminatum (CA) with different prognosis. Methods Immunocytochemical staining with streptavidin-peroxidase (SP) and reverse transcription (RT)-PCR were conducted to detect the expressions of TLR3 and TLR9 in tissue specimens from lesions of 10 patients with recurrent CA, 14 patients with non-recurrent CA as well as from the foreskin of 10 normal human controls. Results TLR3 and TLR9 were mainly distributed in spinous layer and granular layer in non-recur- rent CA lesions, but in basal layer and spinous layer in recurrent CA lesions. A significant elevation was observed in the expression of TLR3 mRNA in non-recurrent CA lesions compared with the control tissue and recurrent CA lesions (P 〈 0.01, 0.05), and in the expression of TLR9 mRNA in non-recurrent CA lesions compared with the control tissue (P 〈 0.05). No significant difference was observed between the recurrent and non-recurrent CA lesions in the expression of TLR9 mRNA. Conclusions The changes in the distribution and expressions of TLR3 and TLR9 in epidermis may be associated with the prognosis of CA, and TLR3 may exert a greater impact.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第5期354-356,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献5

  • 1张建成,丁怡,周总光,李红光,周斌.人乳头状瘤病毒16 E7 DNA在结直肠腺癌组织中的表达[J].生物医学工程学杂志,2005,22(5):1024-1026. 被引量:3
  • 2Finberg RW,Wang JP,Kurt-Jones EA.Toll like receptors and viruses.Rev Med Virol,2007,17(1):35-43.
  • 3Doyle SE,O'Connell R,Vaidya SA,et al.Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.J Immunol,2003,170(7):3565-3571.
  • 4Barton CM,Kagan JC,Medzhitov R.Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA.Nat Immunol,2006,7(1):49-56.
  • 5Hu X,Chen J,Wang L,et al.Crosstalk among Jak-STAT,Toll-like receptor,and ITAM-dependent pathways in macrophage activation.J Leukoc Biol,2007,82(2):237-243.

二级参考文献11

  • 1Kirgan D, Manalo P, Hall M, et al. Association of human papillomavirus and colon neoplasms. Arch Surg, 1990; 125 (10)∶862
  • 2McGregor B, Byrne P, Kirgan D, et al. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg, 1993; 166 (6)∶738
  • 3Lee YM, Leu SY, Chiang H, et al. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect, 2001; 34 (2)∶87
  • 4Audeau A, Han HW, Johnston MJ, et al. Does human papilloma virus have a role in squamous cell carcinoma of the colon and upper rectum? Eur J Surg Oncol, 2002; 28 (6)∶657
  • 5Buyru N, Budak M, Yazici H, et al. p53 gene mutations are rare in human papillomavirus-associated colon cancer. Oncol Rep, 2003; 10 (6)∶2089
  • 6Bosch FX, Munoz N. The viral etiology of cervical cancer. Virus Res, 2002; 89 (2)∶183
  • 7Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res, 1999; 59∶753
  • 8Kirgan D, Manalo P, Mc Gregor, et al. Immunohistochemical demonstration of human papilloma virus antigen in human colon neoplasms. J Surg Res, 1990; 48 (5)∶397
  • 9Shah KV, Daniel RW, Simons JW, et al. Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol, 1992; 51 (1)∶5
  • 10Cheng JY, Sheu LF, Meng CL, et al.Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction.Gut, 1995; 37∶87

共引文献2

同被引文献94

  • 1艾军华,吕凤林,左国伟,金丹,李元朝,胡承香.人乳头瘤病毒11型DNA中CpG基序甲基化状态分析及生物活性的研究[J].免疫学杂志,2005,21(1):29-32. 被引量:4
  • 2Anorlu RI. What is the significance of the HPV epidemic[J].Canadian Journal of Urology,2008,(01):3860-3865.
  • 3Chen K,Huang J,Gong W. Toll-like receptors in inflammation,infection and cancer[J].International Journal of Immunopharmacology,2007,(10):1271-1285.
  • 4Inoue J,Aramaki Y. Toll-like receptor-9 expression induced by tapestripping triggers on effective immune response with CpG-oligodeoxynucleotides[J].Vaccine,2007,(06):1007-1013.
  • 5KawaiT,Akira S.TLR signaling[J].Cell Death Differ,2006,13(5):816-825.
  • 6MatsumotoM,Funami K,Tanabe M,et al.Subcellular localization of Toll-like receptor 3 in human dendritic cells[J].J Immunol,2003,171(9):3154-3162.
  • 7AkiraS,Takeda K.Toll-like receptor signaling[J].Nat Rev Im-munol 2004,4(7):499-511.
  • 8AlegreML,Goldstein DR,Chong AS.Toll-like receptor signaling in transplantation[J].Current Opinion in Organ Transplantation,2008,13(4):358-365.
  • 9George Rozis,Adel Benlahrech,Sai Duraisingham,et al.Human Langerhans ' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands[J].Immunology,2008,124(3):329-338.
  • 10ItohH5Tatematsu M,Watanabe A,et al.UNC93B1 physically as-sociates with human TLR8 and regulates TLR8-mediated signaling[J].PLoS One,2011,6(12):e28500.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部